TheJobsMapAbolerIS Pharma jobs and careers
Nantes, France
About AbolerIS Pharma
AbolerIS Pharma will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases. Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells. IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells. Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.
Founded in 2019 by Carole Guillonneau, F.-Xavier HUBERT and Ignacio Anegon.
- Founded
- 2019
- Employees
- 1 to 10
- Total funding
- $29.8M
- Headquarters
- Nantes
Leadership
The top of AbolerIS Pharma's org chart, with how many people report into each leader.
Ann Meulemans
CEO
6 reports
Benoit Moreaux
Head of Operations-Part Time
3 reports
Philippe Alen
Chief Business Officer (fractional)
Tomas Van Dyck
Chief Financial Officer
Board
Carole Guillonneau
Founder
Olivier Van de Steen
Medical Advisor
Michel Goldman
Director
F.-Xavier Hubert
Founder
Hans-Dieter Volk
Scientific Advisor
Guy Heynen
Director
Jobs at AbolerIS Pharma
No open positions right now. Explore more companies on TheJobsMap.